However, "significant bottlenecks still exist," according to Dominika Suchonova, a spokesperson for MedTech Europe, a European association that represents IVD and medical device makers. Suchonova ...
The updated CE marking now enables labs in Europe to unify their workflows for both cell and tissue slide imaging and processing.
Designed for routine clinical use, the system can identify M-proteins based on their molecular weight to help diagnose multiple myeloma and related disorders.
Legislation passed by the US Senate to reopen the federal government includes a temporary delay to price cuts and data reporting requirements.
NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...
The company said that recent study results show its Aventa Lymphoma test can provide actionable information that would typically be missed by FISH testing.
The El Monte, California, lab services provider increased its full-year 2025 guidance for both its revenues and its adjusted earnings.
Revenues from the Life Sciences business unit, which is on track to be sold to Waters in Q1 2026, rose 2 percent to $1.37 billion.
Third quarter revenues dipped 4 percent as reported but rose 5 percent excluding results from COVID-19 testing and the donor screening business the firm is exiting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback